Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

BioTelemetry (BEAT) Insider Trading & Ownership

BioTelemetry logo

BioTelemetry (NASDAQ:BEAT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.85%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$10,381.16
Get BEAT Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioTelemetry stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BEAT Insider Buying and Selling by Quarter

BioTelemetry Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2024Urioste George DeDirectorSell1,674$2.34$3,917.16  
8/26/2024Urioste George DeDirectorSell300$2.38$714.00  
8/23/2024Urioste George DeDirectorSell2,500$2.30$5,750.00  
(Data available from 1/1/2013 forward)

BEAT Insider Trading Activity - Frequently Asked Questions

The list of insiders at BioTelemetry includes Urioste George De. Learn more on insiders at BEAT.

20.85% of BioTelemetry stock is owned by insiders. Learn more on BEAT's insider holdings.

The following insider sold BEAT shares in the last 24 months: Urioste George De ($76,935.54).

Insiders have sold a total of 35,019 BioTelemetry shares in the last 24 months for a total of $76,935.54 sold.



This page (NASDAQ:BEAT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners